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PICALM modulates autophagy activity
and tau accumulation
Kevin Moreau1,*, Angeleen Fleming1,2,*, Sara Imarisio3, Ana Lopez Ramirez1,2, Jacob L. Mercer4,5,
Maria Jimenez-Sanchez1, Carla F. Bento1, Claudia Puri1, Eszter Zavodszky1, Farah Siddiqi1, Catherine P. Lavau4,
Maureen Betton1,3, Cahir J. O’Kane3, Daniel S. Wechsler4,5 & David C. Rubinsztein1
Genome-wide association studies have identiﬁed several loci associated with Alzheimer’s
disease (AD), including proteins involved in endocytic trafﬁcking such as PICALM/CALM
(phosphatidylinositol binding clathrin assembly protein). It is unclear how these loci may
contribute to AD pathology. Here we show that CALM modulates autophagy and alters
clearance of tau, a protein which is a known autophagy substrate and which is causatively
linked to AD, both in vitro and in vivo. Furthermore, altered CALM expression exacerbates
tau-mediated toxicity in zebraﬁsh transgenic models. CALM inﬂuences autophagy by
regulating the endocytosis of SNAREs, such as VAMP2, VAMP3 and VAMP8, which have
diverse effects on different stages of the autophagy pathway, from autophagosome formation
to autophagosome degradation. This study suggests that the AD genetic risk factor CALM
modulates autophagy, and this may affect disease in a number of ways including modulation
of tau turnover.
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A
lzheimer’s disease (AD) is the most common dementia. Its
brain pathology is characterized by the accumulation and
aggregation of extracellular b-amyloid plaques and
intracytoplasmic tau, the latter correlating better with disease
progression1. (Macro)autophagy is a critical clearance pathway
for organelles and long-lived proteins, including intracytoplasmic
aggregate-prone proteins that cause many neurodegenerative
diseases, such as huntingtin in Huntington’s disease and tau in
AD (reviewed in ref. 2). Furthermore, autophagy protects cells
against proapoptotic insults by reducing caspase activation3. One
of the hallmarks of AD pathology is an excess of autophagosomes
in affected neurons, suggesting that there may be defects in
autophagosome removal4. However, autophagy may be perturbed
at multiple steps in AD, including additional effects at the levels
of autophagosome biogenesis (reviewed in ref. 5), and its
upregulation has beneﬁts in various AD animal models6–8.
Autophagosomes are double-membraned structures that engulf
portions of cytoplasm and ultimately fuse with lysosomes, where
their contents are degraded. Autophagy begins with the formation
of cup-shaped structures called phagophores, whose edges extend
and fuse to form autophagosomes9,10. The ATG5-ATG12/
ATG16L1 complex regulates the initiation of phagophore
formation, while phosphatidylethanolamine-conjugated ATG8/
LC3 (LC3-II) mediates the elongation and fusion of the
phagophore edges to form autophagosomes9,10. The ATG5-
ATG12/ATG16L1 complex decorates the phagophore and
dissociates after completion of autophagosome formation, while
LC3-II is localized to both the phagophore and fully formed
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Figure 1 | CALM modulates autophagy. (a) Western blot analysis of CALM, actin, GAPDH and LC3-II in several cell lines (HeLa, HEK, CAD and murine
embryonic ﬁbroblast (MEF)) where CALM was knocked down using shRNA or siRNA, as indicated, or knockout with rescue experiment. In all experiments
in this paper, we used a scramble siRNA or a luciferase shRNA as controls. The cells were starved in Hanks balanced salt solution (HBSS) and treated with
Baf A1 as indicated. (BC, basal conditions; SE, short exposure; LE, longer exposure). Quantiﬁcation of LC3-II/actin or GAPDH ratio is shown in
Supplementary Fig. 1A. *Not speciﬁc. (b) LC3 dot counting in CALM knockdown cells. CALM was knocked down in HeLa cells expressing GFP-LC3 and with
or without an siRNA-resistant form of wild-type CALM (rescue), as indicated. The cells were starved in HBSS for 4 h, ﬁxed and subjected to microscopy to
score the number of LC3 dots per cell. The knockdown efﬁciency and the level of the siRNA-resistant form of CALM are shown on the left on the western
blotting. The number of LC3 dots per cell (shown as mean ±s.d.) is shown on the graph for each condition (nZ300 cells per condition; BC, basal
conditions). The ratio of the number of LC3 dots per cell between starvation and basal conditions is shown on the right (*Po0.01; NS, not signiﬁcant,
two-tailed t-test). Pictures obtained from automated microscope are shown. Scale bars, 20mm.
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autophagosomes, and its levels correlate with autophagosome
number.
Autophagosomes may derive membrane from diverse
sources, including plasma membrane, recycling endosomes,
Golgi, endoplasmic reticulum and mitochondria11–18. Clathrin-
mediated endocytosis regulates autophagy by enabling membrane
delivery to ATG5/ATG12/ATG16L1-positive phagophore pre-
cursor vesicles (LC3-negative), which mature to form
phagophores (ATG16L1-positive and LC3-positive), and
subsequently autophagosomes (ATG16L1-negative and LC3-
positive)12. The ATG16L1-positive/LC3-negative phagophore
precursors undergo homotypic fusion events that increase their
size and enhance their ability to acquire LC3-II. These fusion
events are mediated by soluble NSF attachment protein receptors
(SNAREs), including VAMP7, syntaxin 7, syntaxin 8 and VTI1B,
although our data suggested that additional SNAREs were likely
to be mediators of this process as well16. Maturation of the
ATG16L1-positive precursors also requires VAMP3-mediated
fusion with ATG9-positive vesicles in recycling endosomes18.
Interestingly, VAMP3 depletion does not affect ATG16L1
homotypic fusion18. SNAREs also regulate autophagosome
degradation. For instance, VAMP8 on lysosomes associates with
partner SNAREs such as VTI1B on autophagosomes to enable
fusion of these compartments19.
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Figure 2 | CALM modulates autophagy substrate clearance in vitro. (a) p62 vesicle formation in CALM knockdown HeLa cells. Confocal pictures are
shown. #CALM-downregulated cells where p62 vesicles accumulate. Data are representative of three independent experiments and shown as mean
±s.e.m. (nZ500 cells; *Po0.01; two-tailed t-test). Scale bars, 5 mm. (b) Western blot analysis of p62, actin and GAPDH in HeLa cells and HEK cells (basal
conditions, BC, or without serum for 1 h) where CALM was knocked down using shRNA or siRNA, as indicated. Data are mean±s.d (n¼ 3 experiments for
HeLa cells and HEK cells; *Po0.05; two-tailed t-test). (c) Percentage of Q74-expressing cells with aggregates in CALM knockdown HeLa cells. Data depict
one representative experiments performed in triplicate, out of three independent experiments and shown as mean ±s.d. (*Po0.05; two-tailed t-test).
(d) Tau-positive tangle formation in CALM knockdown cells. HeLa cells transiently expressing DsRed-tau 4R were treated with Baf A1 for 4 h as indicated.
Cells were ﬁxed and analysed by confocal microscopy after immnunostaining for phosphorylated tau using PHF1 antibody (green). Data represent the
number of cells with phosphorylated tau-positive tangles as mean ±s.e.m. (n¼ 3 experiments; *Po0.01; two-tailed t-test). Scale bars, 5 mm.
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5998 ARTICLE
NATURE COMMUNICATIONS | 5:4998 | DOI: 10.1038/ncomms5998 | www.nature.com/naturecommunications 3
& 2014 Macmillan Publishers Limited. All rights reserved.
Recent genome-wide association studies (GWAS) have identi-
ﬁed several loci associated with AD risk20,21. It is unclear how
most of these have an impact on the genesis of AD. Although no
direct autophagy genes were identiﬁed, these loci encode a
number of genes involved in endocytic trafﬁcking. One of these,
PICALM (also known as CALM), has been validated in
independent studies22–24. Phosphatidylinositol-binding clathrin
assembly protein (PICALM/CALM) appears to be abnormally
cleaved in AD samples and levels of uncleaved full-length CALM
are signiﬁcantly decreased in AD brains, suggesting that
decreased CALM function may be relevant in this disease25.
CALM encodes a clathrin adaptor that regulates the orderly
progression of coated bud formation at the plasma membrane. It
directly interacts with and thereby regulates the endocytosis of
SNAREs, such as VAMP2, VAMP3 and VAMP8 (refs 26,27). As
endocytosis and SNAREs both regulate autophagy, we tested the
role of CALM in autophagy and its relevance in a model of
neurodegeneration in vivo. We found that CALM regulates
autophagy and clearance of tau, an autophagy substrate, thus
providing a potential mechanism by which CALM levels might
inﬂuence the severity of AD.
Results
CALM modulates autophagy. We tested the role of CALM in
autophagy and observed increased LC3-II levels in HeLa, HEK
(human embryonic kidney), CAD (catecholaminergic cell line)
and primary neurons, where CALM was knocked down using
short hairpin RNA (shRNA) or small interfering RNA (siRNA)
under basal conditions (BCs), and in HeLa, HEK and CAD cells
exposed to serum starvation, an autophagy stimulus (Fig. 1a and
Supplementary Fig. 1a,b)28. The increase in LC3-II levels due to
CALM depletion was rescued in CALM-null mouse embryonic
ﬁbroblasts by reintroducing CALM using a viral system (Fig. 1a).
These experiments suggest that CALM deﬁciency inﬂuences
autophagy, either by stimulating autophagosome formation or by
inhibiting their degradation, both of which increase LC3-II levels.
To discriminate between these possibilities, LC3-II levels was
measured in the presence of saturating concentrations of
baﬁlomycin A1 (Baf A1), a potent inhibitor of the vacuolar
Hþ ATPase that interferes with the degradation of
autophagosomes/LC3-II by preventing lysosomal acidiﬁcation28.
CALM knockdown decreased LC3-II levels in the presence of Baf
A1 in BCs in HeLa cells and primary neurons, suggesting reduced
autophagosome formation (Fig. 1a and Supplementary Fig. 1a,b).
This effect remained robust when autophagy was stimulated by
starvation, where CALM knockdown decreased the amount of
LC3-II in the presence of Baf A1 by about 40% in HeLa cells
(Fig. 1a and Supplementary Fig. 1a). This is similar to the effects
seen when we knock down key autophagy genes16 as well as genes
involved in clathrin-mediated endocytosis12. The decreased
LC3-II levels in Baf A1-treated conditions and the increase of
LC3-II in Baf A1-untreated conditions suggest that CALM
modulates both autophagosome synthesis and autophagosome
degradation. To further characterize the role of CALM in
autophagy, we used another assay to measure autophagy. LC3
dot numbers (autophagosomes) increased in CALM knockdown
cells compared with control in BCs (Fig. 1b), which, if viewed in
isolation, could be either due to an increase in autophagosome
formation or a defect in their clearance. Serum starvation
increased the number of LC3 dots per cell in control cells, but
caused no further increase above nutrient-replete medium in
CALM knockdown cells (Fig. 1b), suggesting that CALM indeed
affects both autophagosome biosynthesis and autophagosome
clearance, consistent with the LC3 western blotting data above.
We conﬁrmed that an siRNA-resistant myc-CALM construct
could rescue the autophagy defect caused by CALM siRNA
(Fig. 1b). Thus, CALM knockdown appears to regulate both
autophagosome formation and degradation. These have opposing
effects on basal LC3-II levels, but CALM knockdown has
clear effects on autophagosome biogenesis when we clamp
LC3 degradation with Baf A1, or score autophagic vesicles in
starved cells.
CALM overexpression, which affects clathrin-mediated trafﬁc
when expressed at high levels29, also decreased autophagosome
formation, as assessed by LC3-II levels (with or without Baf A1)
(Supplementary Fig. 1c). The inhibition of autophagosome
formation in CALM-overexpressing cells was associated with
decreased transferrin uptake (Supplementary Fig. 1d), suggesting
decreased endocytosis, but did not affect endocytosis of various
SNAREs (VAMP2, VAMP3 and VAMP8; Supplementary Fig. 1f).
A CALM mutant that includes the ANTH domain but not the
clathrin-interacting domain (and which did not inhibit
transferrin uptake, Supplementary Fig. 1d) did not decrease
autophagy, as had similar LC3-II levels to control cells
(Supplementary Fig. 1c). The role of CALM in transferrin
internalization is controversial26,29,30. Although CALM seems to
inﬂuence transferrin uptake in vivo in CALM-knockout mice31, it
is not so clear in vitro30,32. We observed no defect in transferrin
internalization with CALM knockdown, while we observed a clear
defect in epidermal growth factor uptake (Supplementary Fig. 1e).
These data raise the question of whether CALM regulates only
endocytosis of speciﬁc substrates, rather than bulk clathrin-
mediated endocytosis33. Our data suggest that CALM
Figure 3 | CALM regulates the formation and maturation of autophagic precursors. (a) Formation of endogenous ATG12 vesicles in CALM knockdown
HeLa cells in basal (BC) and serum starvation conditions. Confocal pictures are shown with arrows indicating ATG12 vesicles in starvation conditions.
Data are from one representative experiment, out of three independent experiments. Data shown as mean ±s.e.m. (nZ500 cells; *Po0.01; two-tailed
t-test). Scale bars, 5 mm. (b) Co-localization between GFP-ATG16L1 and internalized cholera toxin subunit B conjugated with Alexa555 (CTX; 20min) in
CALM knockdown HeLa cells. Confocal pictures are presented with magniﬁed areas showing the co-localization between ATG16L1 and CTX in greater
detail. Scale bars, 5 mm. The Pearson’s coefﬁcient between ATG16L1 and cholera toxin is shown. Data are representative of three independent experiments
and shown as mean±s.d. (nZ20 cells; *Po0.05; two-tailed t-test). (c) Size of endogenous ATG12 vesicles in CALM knockdown HeLa cells in starvation
conditions. Confocal pictures are shown with arrows indicating ATG12 vesicles and # indicating CALM knockdown cells. Data are representative of three
independent experiments and shown as mean ±s.d. (nZ100 vesicles; *Po0.05; two-tailed t-test). (AU, arbitrary unit). Scale bars, 5 mm. (d) Live-cell
imaging of ATG16L1-GFP in CALM knockdown HeLa cells. Confocal pictures from various time points of a 5-min movie are shown in inverted grey style.
Arrows indicate ATG16L1 vesicles. The number of fusion events per 5min is shown. Data are representative of ﬁve movies and shown as mean ±s.d.
(*Po0.05; two-tailed t-test). Scale bars, 5 mm. (e) In vitro fusion assay of post-nuclear supernatant from HeLa cells expressing either GFP-ATG16L1 or
mStrawberry-ATG16L1 in control and CALM knockdown conditions. Confocal pictures are shown where ATG16L1-mStrawberry signal is shown in purple
to enable better visualization. Fused vesicles appear in white. The ATP-negative condition, which prevents SNARE-dependent fusion, is also shown
as a control for the reaction. Magniﬁed areas are shown to allow visualization of the vesicles. The percentage of fused vesicles is represented. n¼ numbers
of vesicles scored per ﬁeld (a minimum of ﬁve ﬁelds were analysed per condition). Data are representative of two independent experiments and shown
as mean ±s.d. (nZ100 vesicles). Scale bars, 5 mm. (*Po0.05; two-tailed t-test).
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knockdown, which affects SNARE endocytosis32 (conﬁrmed later
in this paper), decreases both autophagosome formation and
autophagosome clearance. On the other hand, CALM
overexpression does not affect VAMP2, VAMP3 or VAMP8
endocytosis and predominantly inhibits autophagosome
biogenesis without affecting autophagosome clearance.
The inhibition of autophagosome formation and degradation
when CALM was downregulated was associated with the
accumulation of autophagic substrates, as measured by the
number of endogenous p62 dots per cell, p62 levels by western
blotting or the number of mutant huntingtin (Q74) aggregates
per cell (huntingtin mutant with 74 glutamine repeats) (Fig. 2ac).
Both of these proteins aggregate when autophagy is impaired and
the number of mutant huntingtin aggregates correlates linearly
with protein abundance under normal conditions34. We also
observed an accumulation of AD associated tau, another
autophagy substrate, and its phosphorylated form (using PHF1
antibody) by immunoﬂuorescence in structures resembling tau
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tangles (a hallmark of AD) in cells expressing DsRed-tau 4R when
autophagy was inhibited by Baf A1 or when CALM was knocked
down (Fig. 2d).
CALM regulates autophagic precursor formation. To under-
stand how CALM affects autophagy, we assessed the localization
of endogenous CALM on autophagic structures associated with
endogenous ATG12 and LC3. First, co-localization between
CALM and AP2 conﬁrmed that our CALM immunostaining was
speciﬁc because both proteins are known to be localized in
clathrin-coated vesicles (Supplementary Fig. 2a). Furthermore, we
observed CALM on ATG12 vesicles that did not contain LC3
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Figure 4 | CALM affects autophagy via SNARE endocytosis. (a) LC3 levels in CALM knockdown cells. CALM was knocked down in cells expressing
or not expressing an siRNA-resistant form of CALM wild type (wt) or CALM 219 mutant, as indicated. The cells were lysed and subjected to western
blotting. The knockdown efﬁciency, LC3-II levels and the level of the siRNA-resistant form of CALM are shown on the western blotting. (b) LC3 dots
counting in CALM knockdown cells. CALM was knocked down in cells expressing GFP-LC3 with or without an siRNA-resistant form of CALM wild type
(wt) or CALM mutant (219 mutant) as indicated. The cells were kept in full medium or starved in Hanks balanced salt solution (HBSS) for 4 h, ﬁxed and
subjected to microscopy to score the number of LC3 dots per cell. The ratio of the number of LC3 dots per cell (shown as mean±s.d.) between starvation
and basal conditions is shown on the graph (*Po0.01; NS, not signiﬁcant, two-tailed t-test; nZ300 cells per condition; BC, basal conditions).
(c) Co-localization between ATG9A and VAMP3-HA or GFP-LC3 and VAMP8-HA in control and CALM knockdown HeLa cells stably expressing
VAMP3-HA or VAMP8-HA. Confocal pictures are shown with magniﬁed areas showing co-localization between ATG9A and VAMP3 or GFP-LC3 and
VAMP8 in control cells and no co-localization in CALM knockdown cells. Quantiﬁcation of ATG9A-VAMP3 or GFP-LC3-VAMP8 co-localization is shown
on the graph as a Pearson’s coefﬁcient (data are mean ±s.d.; *Po0.05; two-tailed t-test). Scale bars, 5mm.
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(phagophore precursors), as well as on vesicles positive for both
ATG12 and LC3 (phagophores), suggesting that autophagic
precursors acquire CALM at an early stage of autophagosome
formation (Supplementary Fig. 2a). The presence of CALM
on ATG12 vesicles was increased in cells expressing a mutant
form of ATG4B (ATG4B C74A) that impairs the progression
from phagophores to autophagosomes35, further supporting the
presence of CALM on early autophagic structures (Supplemen-
tary Fig. 2a). We conﬁrmed the localization of CALM on
autophagic precursors by immuno-electron microscopy, where
CALM co-localized with ATG16L1 (Supplementary Fig. 2b).
Given the presence of CALM on autophagic precursors, we
studied the effects of CALM depletion on the formation of these
precursors. CALM knockdown reduced the numbers of endo-
genous ATG12 vesicles or GFP-ATG16L1 vesicles per cell and the
association of plasma membrane with autophagic precursors, as
measured by the co-localization of GFP-ATG16L1 and inter-
nalized cholera toxin (used as a plasma membrane tracer)
(Fig. 3a,b and Supplementary Fig. 2c)12. This phenocopied what
we observed when we impaired clathrin-mediated endocytosis by
knocking down either clathrin heavy chain or AP2 (ref. 12).
These data suggest that one mechanism for the effect of CALM
deﬁciency on autophagosome biogenesis is by reducing the levels
of ATG5/ATG12/ATG16L1-positive phagophore precursors,
which correlates with a subsequent defect in autophagosome
formation12. However, we noted that the size of the ATG12
vesicles or ATG16L1-GFP vesicles was also smaller in CALM
knockdown cells (Fig. 3c and Supplementary Fig. 2d). We
therefore investigated the impact of reduced CALM levels on
ATG16L1 homotypic fusion. Using live imaging, we conﬁrmed
fewer homotypic fusion events involving such phagophore
precursors in CALM knockdown cells (Fig. 3d and
Supplementary Movies 1 and 2). However, this assay may be
misleading by itself, if one starts with fewer vesicles. Another way
to measure the rate of fusion events between ATG16L1 vesicles is
to perform an in vitro fusion assay between such vesicles derived
from cells expressing either green ﬂuorescent protein (GFP)- or
mStrawberry-tagged ATG16L1, as previously described16.
In this assay, the fusions are expressed as a function of the
number of vesicles. As we also observed fewer fusion events using
ATG16L1 vesicles from CALM knockdown cells (Fig. 3e), it is
possible that CALM regulates the levels of proteins that are
required for these fusion events, such as SNAREs16. The absence
of ATP in the system abolished the fusion between two sets of
vesicles, consistent with a role for SNAREs in the process
(Fig. 3e)16.
We recently described another step required for
autophagosome formation that may be relevant to CALM.
ATG16L1-positive precursors undergo heterotypic fusion with
ATG9A-positive vesicles and this is important for subsequent
maturation of these autophagic precursors into autophago-
somes18. Therefore, we assessed the interaction between
ATG16L1 and ATG9A vesicles using confocal microscopy. We
observed a decrease in ATG16L1-ATG9A co-localization in
CALM knockdown cells (Supplementary Fig. 2e), suggesting a
level of regulation at early steps of autophagosome biogenesis by
CALM. Moreover, we observed a decrease in LAMP1-LC3 co-
localization in CALM knockdown cells (Supplementary Fig. 2f),
suggesting a defect in autophagosome/lysosome fusion, which
could explain the increase in LC3-II levels seen on western
blotting (as shown in Fig. 1a).
CALM-dependent SNARE endocytosis is required for
autophagy. Our observations that CALM knockdown affects both
autophagosome formation associated with defects at both
homotypic and heterotypic fusion steps, as well as impaired
autophagosome degradation associated with defective autopha-
gosome/lysosome fusion is consistent with defects in the func-
tions of diverse SNAREs. CALM regulates the endocytosis of
many SNAREs, such as VAMP2, VAMP3 and VAMP8 (ref. 27).
VAMP3 regulates heterotypic fusion between ATG16L1 and
ATG9A precursors, and is associated with ATG9A-containing
vesicles emanating from the plasma membrane18, while VAMP8
has been shown to regulate autophagosome–lysosome fusion19,
and nothing is known about the role of VAMP2 in autophagy. To
test the possibility that CALM modulates autophagy via its role in
SNARE endocytosis, we used a previously characterized siRNA-
resistant form of CALM mutated in the SNARE binding site
(CALM 219 mutant)32. We observed an increase of LC3-II in
CALM knockdown cells, as seen previously (Fig. 4a). Although
the expression of siRNA-resistant wild-type CALM in the
knockdown cells was able to reduce the levels LC3-II to control
levels, an siRNA-resistant CALM 219 mutant (that rescued EGF
uptake but not SNAREs internalization) was not able to rescue
the LC3-II levels, as seen by the increase of LC3-II compared with
the control (Fig. 4a and Supplementary Fig. 3a). The inability of
this CALM mutant to rescue CALM knockdown was also
observed by microscopy, when we assessed the number of LC3
dots in basal or starvation conditions (Fig. 4b). Although the
wild-type CALM-expressing cells were able to produce new
autophagosomes on starvation (as seen by the ratio of the number
of LC3 dots per cell between starvation and BCs), the mutant
CALM was not able to do so (Fig. 4b). These data suggest that the
effects of CALM knockdown on autophagy can be attributed to
the role of CALM in regulating endocytosis of SNAREs, such as
VAMP2, VAMP3 and VAMP8. Consistent with this hypothesis,
we observed decreased ATG9A/VAMP3 co-localization (regulat-
ed by VAMP3 (ref. 18)) and LC3/VAMP8 co-localization
(regulated by VAMP8 (ref. 19)) in CALM knockdown cells,
where these two SNAREs accumulated at the plasma membrane
(Fig. 4c). Consistent with a role for VAMP3 in autophagosome
biogenesis, we observed decreased LC3 vesicles and elevated p62
dots with VAMP3 knockdown (Supplementary Fig. 3b,d).
Similarly, VAMP8 knockdown increased the numbers of p62
dots and elevated LC3-II levels in the absence of Baf A1, while
having minimal effects in the presence of Baf A1, consistent with
previous data showing that this would impair autophagosome
degradation19 (Supplementary Fig. 3b–d).
VAMP2 endocytosis is required for autophagosome formation.
Among the SNAREs whose endocytosis is regulated by CALM, no
data are available on VAMP2 and autophagy. We conﬁrmed that
CALM regulates VAMP2 endocytosis by assessing its localization
at the plasma membrane when CALM was knocked down in a
stable cell line expressing VAMP2-HA (Fig. 5a)26,27. VAMP2
was localized to autophagic precursors (ATG12-positive) in
both basal and autophagy-stimulated (starvation) conditions
(Supplementary Fig. 4a), and CALM knockdown decreased the
co-localization between ATG12 and VAMP2 (Fig. 5a), suggesting
that VAMP2 may play a role in autophagic precursor formation/
maturation. VAMP2 knockdown decreased LC3-II levels in cells
in the presence of Baf A1, to a similar extent as we observed
previously with SNAREs such as VAMP7 (ref. 16), suggesting
that VAMP2 is involved in autophagosome formation (Fig. 5b).
Distinct single siRNAs against VAMP2 also decreased LC3-II
levels in Baf A1-treated cells (Supplementary Fig. 4b). The
increased LC3-II levels in VAMP2-knockdown cells in the
absence of Baf A1 may be due to decreased autophagosome
degradation, in addition to decreased autophagosome formation,
as seen with CALM depletion. We observed that the number of
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LC3 dots per cell increased in VAMP2 knockdown cells, in BCs
(using two different siRNAs; Fig. 5c), suggesting a defect in
autophagosome clearance. On starvation, the number of LC3 dots
per cell increased in control cells, but we observed no further
increase in VAMP2 knockdown cells (Fig. 5c). Thus, it appears
that much similar to CALM, VAMP2 affects both autophagosome
biosynthesis and autophagosome clearance. VAMP2 knockdown
also increased the number of p62 dots per cell and the number of
Q74 aggregates per cell (Fig. 5d,e), conﬁrming a functional defect
in autophagy substrate clearance.
Higher LC3-II levels were seen in a stable cell line over-
expressing higher levels of VAMP2-HA, compared with one
expressing lower levels of this protein (Supplementary Fig. 4c).
As CALM affects VAMP2 endocytosis, we hypothesized that
VAMP2 endocytosis mediated by CALM is required for effective
autophagy. We used two pairs of stable cell lines with either high
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or low level expression of wild-type VAMP2-HA or a VAMP2-
HA construct in which the CALM binding site was mutated
(V43A and M46A, referred to as AA), trapping VAMP2 at the
plasma membrane27. The cells expressing the VAMP2-HA
mutant had signiﬁcantly decreased autophagosome formation as
demonstrated by the reduced LC3-II levels in the presence or
absence of Baf A1 (Fig. 5f). The cells expressing the VAMP2-HA
mutant spread more efﬁciently than wild-type cells or HeLa cells
but did not have integrin b1-trafﬁcking defects, which could have
explained this phenotype (Supplementary Fig. 4d,e). Thus, the
increased spreading of mutant cells is unlikely to be due to
integrin trafﬁcking but could be explained by decreased
autophagic degradation of different proteins involved in cell
migration, as observed previously36.
The cells with mutant VAMP2-HA also displayed smaller
ATG12 vesicles compared with wild-type VAMP2-HA cells
(Fig. 6a). Thus, we considered that VAMP2 may regulate
homotypic fusion of ATG5/ATG12/ATG16L1 vesicles, as we
observed with CALM. This possibility was reinforced when we
also observed less co-localization between ATG12 and LC3 in
VAMP2-HA mutant cells, compared with wild-type cells
(Fig. 6b). This is a phenotype we observed previously when
ATG16L1-positive autophagic precursor homotypic fusion was
disrupted, and it correlates with impaired maturation of
phagophore precursors into phagophores16. Indeed, VAMP2
knockdown reduced the size of ATG12 vesicles while increasing
their number (Fig. 6c), similar to what we previously observed
when we affected homotypic fusion of these vesicles16. We
observed fewer homotypic fusion events of these vesicles assessed
with live imaging (Fig. 6d and Supplementary Movies 3 and 4).
Furthermore, VAMP2 knockdown also decreased the homotypic
fusion efﬁciency of these vesicles in vitro (Fig. 6e), suggesting that
VAMP2 is an additional SNARE that assists this process
(consistent with its CALM-dependent localization on these
vesicles). However, VAMP2 knockdown had no effect on
ATG16L1-ATG9A co-localization, suggesting that it has no
effect on heterotypic fusion (Supplementary Fig. 2e), a ﬁnding
that mirrors our previous work showing that VAMP3 has no
effect on ATG16L1 homotypic fusion18.
CALM modulates autophagy and tau accumulation in
Drosophila. GWAS studies have identiﬁed that CALM is associ-
ated with AD risk20,21. However, it is unclear how CALM impacts
the development of AD. We hypothesized that it could be via its
regulation of autophagy activities, which would impact tau
clearance. In vivo, we observed that downregulation of the
Drosophila CALM homologue, lap, using two independent RNA
interference (RNAi) lines (lapGD12732 or lapKK105767, whose
sequences do not overlap)37 or the heterozygous loss-of-
function lap1 allele38 (Fig. 7ai), increases the level of Atg8a-II
(Fig. 7aii), the closest Drosophila homologue of mammalian
LC3-II (ref. 39), like mammalian CALM knockdown (Fig. 1). To
study whether lap inﬂuences tau levels in vivo, we generated
Drosophila overexpressing wild-type human tau (4R isoform).
This transgenic line has no phenotype with regard to lethality,
eye degeneration, locomotor activity, wing development and
pseudopupil degeneration when we drive the transgene in
diverse tissues (summarized in Supplementary Table 1 and
Supplementary Fig. 5). This model expresses tau at much lower
levels (o15%) compared with a model with overt phenotypes
(Supplementary Fig. 5a)40. When we reduced Drosophila lap
levels (using either RNAi or heterozygous allele lap1) in ﬂies
expressing human tau in neurons, we observed an increased
human tau/actin ratio (Fig. 7b).
CALM and autophagy contribute to tau clearance in zebraﬁsh.
Although the Drosophila tools enable study of the effects of
CALM knockdown in relation to tau, we used zebraﬁsh to
examine the effects of CALM overexpression. We used this
approach in favour of performing knockdown with morpholino
oligonucleotides, as the two PICALM-like genes in zebraﬁsh
would probably necessitate silencing both genes, and the ‘gold
standard’ validation for these assays (performing rescue experi-
ments by co-injection of messenger RNA) would be practically
impossible due to the effects resulting from overexpression.
CALM overexpression decreased LC3-II levels in the zebraﬁsh
with or without ammonium chloride (NH4Cl), which mimics Baf
A1 treatment (Fig. 8a), similar to what we observed in HeLa cells
(Supplementary Fig. 1c).
To analyse whether CALM overexpression inﬂuenced the
clearance of an AD-relevant autophagy substrate, we studied tau5.
We generated an expression construct comprising a green-to-red
photoconvertible ﬂuorescent protein fused to human tau
(Dendra-tau), which could be mosaically expressed in epithelial
and muscle cells of zebraﬁsh to measure tau clearance
in vivo. Mosaic Dendra-tau ﬁsh were imaged before and after
photoconversion and then daily, to assess clearance of the
red (photoconverted) ﬂuorescently tagged tau protein
(Supplementary Fig. 6a,b). The autophagy-enhancing drugs
rapamycin, clonidine and rilmenidine led to decreased
abundance of red Dendra-tau (Fig. 8b and Supplementary
Fig. 6b), and ammonium chloride (NH4Cl) treatment slowed
Figure 5 | VAMP2 regulates autophagosome formation. (a) Co-localization between ATG12 and VAMP2-HA in control and CALM knockdown HeLa cells
stably expressing VAMP2-HA. Confocal pictures are shown with magniﬁed areas on the right showing co-localization between ATG12 and VAMP2 in
control cells and no co-localization in CALM knockdown cells. Quantiﬁcation of ATG12-VAMP2 co-localization is shown on the graph as the Pearson’s
coefﬁcient (data are mean ±s.d.;*Po0.05; two-tailed t-test). Scale bars, 5mm. (b) Western blot analysis of VAMP2, actin and LC3-II in HeLa cells
where VAMP2 was knocked down, as indicated. The cells were starved in Hanks balanced salt solution (HBSS) and treated with Baf A1 as indicated.
(SE, short exposure; LE, longer exposure.) Quantiﬁcation of LC3-II/actin ratio is shown. Data are representative of three independent experiments and
shown as mean ±s.d. (*Po0.05; NS, not signiﬁcant, two-tailed t-test). (c) LC3 dot counting in CALM and VAMP2 knockdown cells. CALM or VAMP2
were knocked down in cells expressing GFP-LC3. The cells were kept in full medium or starved in HBSS for 4 h, ﬁxed and subjected to automated
ﬂuorescence microscopy to score the number of LC3 dots per cell. The number of LC3 dots per cell (shown as mean±s.d.) is shown on the graph for each
condition (nZ300 cells per condition; BC, basal conditions). (*Po0.01; NS, not signiﬁcant, two-tailed t-test). (d) Number of p62 dots per cell in VAMP2
knockdown. HeLa cells where VAMP2 was knocked down were ﬁxed and subjected to microscopy after labelling endogenous p62 using speciﬁc antibody.
The data represent the number of p62 dots per cell shown as mean ±s.d. (*Po0.05; two-tailed t-test; nZ300 cells per condition). (e) Percentage of
Q74-expressing cells with aggregates in VAMP2 knockdown HeLa cells. Data are from one representative experiments performed in triplicate, out of
three independent experiments and shown as mean±s.d. (*Po0.05; two-tailed t-test). (f) Western blot analysis of VAMP2, actin and LC3-II in HeLa cells
stably expressing VAMP2-HA wild type or VAMP-2-HA mutated in the CALM-binding site at different levels (wild-type clone 6, wt Cl6: low level; wild-type
clone 11, wt Cl11: high level; mutant clone 11, AA Cl11: low level; mutant clone 12, AA Cl12: high level). The cells were treated with Baf A1 as indicated.
(SE, short exposure; LE, longer exposure). Quantiﬁcation of LC3-II/actin ratio is shown. Data are representative of three independent experiments and
shown as mean ±s.d. (*Po0.05; two-tailed t-test).
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Figure 6 | VAMP2 regulates autophagic precursor maturation. (a) Size of endogenous ATG12 vesicles in HeLa cells stably expressing either wild-type or
mutant VAMP2. Confocal pictures are presented with magniﬁed areas showing ATG12 vesicles. Data are representative of three independent experiments
and shown as mean±s.d. (nZ100 vesicles; *Po0.05; two tail t-test). Scale bars, 5 mm. (b) Co-localization between ATG12 and LC3 in HeLa cells stably
expressing either wild-type clone 11 or mutant clone 12 VAMP2. Confocal pictures are presented with magniﬁed areas showing ATG12-LC3 co-localization.
The Pearson’s coefﬁcient between ATG12 and LC3 is shown. Data are representative of three independent experiments and shown as mean ±s.d.
(nZ100 vesicles; *Po0.05; two-tailed t-test). Scale bars, 5 mm. (c) Size and number of endogenous ATG12 vesicles in VAMP2-knockdown HeLa cells in
starvation condition. Confocal pictures are shown with arrows indicating ATG12 vesicles. Data are representative of three independent experiments and
shown as mean ±s.d. for the size of ATG12 vesicle. (nZ100 vesicles; *Po0.05; based two-tailed t-test). Scale bars, 5 mm. (d) Live-cell imaging of
ATG16L1-GFP in VAMP2-knockdown HeLa cells. Confocal pictures from various time points of a 5-min movie are shown in inverted greyscale. Arrows
indicate ATG16L1 vesicles. The number of fusion events per 5min is shown. Data are representative of ﬁve movies and shown as mean±s.d. (*Po0.05;
two-tailed t-test). Scale bars, 5 mm. (e) In vitro fusion assay of post-nuclear supernatants from control and VAMP2 knockdown HeLa cells expressing either
GFP-ATG16L1 or mStrawberry-ATG16L1. Confocal pictures are shown where ATG16L1-mStrawberry signal is shown in purple to enable better visualization.
Fused vesicles appear in white. The ATP-negative condition, which prevents SNARE-dependent fusion, is also shown as a control of reaction. Magniﬁed
areas are shown to allow visualization of the vesicles. The percentage of fused vesicles (white) is represented. Data are representative of two independent
experiments and shown as mean ±s.d. (nZ100 vesicles). Scale bars, 5 mm. (*Po0.05; two-tailed t-test). n¼ numbers of vesicles scored per ﬁeld.
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the clearance of red Dendra-tau (Fig. 8b), suggesting that tau
clearance is, at least in part, mediated via autophagy. Note that
the NH4Cl in this assay is likely to be non-saturating, as complete
autophagy/lysosome function compromise for a prolonged period
in the whole organism would result in lethality. Co-injection of
full-length CALM led to a marked reduction in the clearance of
Dendra-tau compared with clearance with co-injection of CALM
expressing the ANTH domain (Fig. 8c and Supplementary
Fig. 6c). To determine whether this delay in tau clearance was a
result of defective autophagy, zebraﬁsh larvae injected with
CALM and Dendra-tau were treated with ammonium chloride.
Ammonium chloride treatment caused a 70% increase in the
levels of Dendra-tau in larvae co-injected with CALM expressing
the ANTH domain, demonstrating that inhibition of autophagy
alters the tau clearance dynamics to a level similar to that of
larvae injected with full-length CALM (Fig. 8c). In addition,
ammonium chloride also caused a modest (22%) decrease in the
clearance of full-length CALM, suggesting that ammonium
chloride or CALM overexpression alone reduce, but do not
completely block, autophagy and that together they have an
additive effect.
To examine the consequences of CALM overexpression on tau
toxicity, we developed a zebraﬁsh model expressing enhanced
GFP (EGFP)-tagged human tau under the control of the
rhodopsin promoter to drive expression in the rod photorecep-
tors (rho::GFP-tau). We observed normal development of the rod
photoreceptors expressing EGFP-tau from 3 days post fertiliza-
tion (d.p.f.) to 6 d.p.f., then degeneration from 7 d.p.f. onwards,
initially within the central retinal region and then at the
margins (Supplementary Fig. 7a,b). Western blotting and
immunohistochemistry for rhodopsin, the major component of
the rod outer segment (Supplementary Fig. 7c), conﬁrmed that
the loss of EGFP-tau photoreceptors was truly degeneration of the
rods rather than transgene downregulation. Accordingly, in
subsequent experiments, we used the presence of EGFP-tau-
positive photoreceptors as a proxy for assessing neurodegenera-
tion. Before degeneration, we observed phosphorylation of the
transgenic human tau protein at speciﬁc serine and threonine
residues (Supplementary Fig. 7d); such phosphorylation is a
hallmark of tau pathology in human and can be used as an
indicator of disease progression41,42. The degeneration was
conﬁrmed by increased numbers of apoptotic cells in the retina
of rho::GFP-tau compared with rho::GFP ﬁsh (a control
transgenic line expressing GFP under the rhodopsin promoter)
at 7 d.p.f. (Supplementary Fig. 7e). Rod photoreceptor
degeneration was prevented by treatment with rapamycin
(Fig. 9a) and exacerbated by the autophagy blockers
wortmannin and NH4Cl (Fig. 9a), suggesting that autophagy
manipulation can alter disease progression in this model, as
described in other systems10. We developed a novel
electroporation technique to deliver exogenous DNA to the
photoreceptor layer of larval zebraﬁsh (Supplementary Fig. 7f)
and used this approach to overexpress CALM in the
photoreceptors of rho::GFP-tau ﬁsh or rho::GFP ﬁsh to
investigate the effects of CALM expression on tau-induced
pathology. CALM overexpression in the photoreceptor layer
accelerated rod photoreceptor degeneration and increased the
number of apoptotic photoreceptors in rho::GFP-tau but did not
cause any signs of pathology in the rho::GFP ﬁsh (Fig. 9b and
Supplementary Figs 7e and 8a,b). To investigate whether
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neuroﬁbrillary tangles were evident, we blocked cell death by
treatment with the caspase inhibitor Z-VAD-FMK, to prolong
photoreceptor survival. Thioﬂavin-S-positive tangles were
observed in the photoreceptor layer of rho::GFP-tau ﬁsh, but
not rho::GFP ﬁsh (Fig. 10). The accelerated degeneration
following CALM overexpression was associated with increased
tau phosphorylation and accumulation of thioﬂavin-S-positive
tangles (Fig. 10b and Supplementary Fig. 8c). To validate that this
degeneration was caused by autophagic impairment, we treated
electroporated ﬁsh with autophagy-inducing (rapamycin) or -
inhibiting (NH4Cl) drugs that modulated tau toxicity (Fig. 9a).
NH4Cl exacerbated the photoreceptor degeneration in the control
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eye (as observed previously, Fig. 9a) such that the control eye and
the electroporated eye showed equal levels of degeneration
(Fig. 9c). Rapamycin rescued photoreceptor degeneration in the
control eye but was unable to rescue the degeneration in the
electroporated eye (Fig. 9c). Although rapamycin can induce
autophagy and rescue degeneration in the control eye, our data
suggest that CALM disrupts autophagosome biogenesis and
therefore rapamycin treatment is unable to rescue degeneration in
the CALM-electroporated eye, as autophagy upregulation via
target of rapamycin inhibition cannot overcome the deﬁcit in
autophagosome formation caused by CALM. These data suggest
that the effects of CALM on tau toxicity in this model are
autophagy dependent.
Discussion
One of the challenges of the post-genomic era is to understand
how genes identiﬁed in association studies have an impact on
disease. Our study suggests that at least one relevant way that
CALM may inﬂuence AD development is by regulating
autophagy. This is likely to have pleiotropic effects, and at least
one of these may be via tau accumulation. Tau is an autophagy
substrate5 and its accumulation in aggregates is a better indicator
of functional impairment than the amount of extracellular
b-amyloid in AD1. Although known ATG genes have not been
associated with AD, this is not necessarily surprising. First, to
have a chance of seeing a signal for such genes in GWAS, one
needs to have allelic variants present above a certain frequency
(depending on sample size) that have an impact on autophagy
activity. If no such variants exist at this frequency, then no valid
signal will emerge. Second, hemizygous loss of most of these
genes has no effect on autophagy in mice, and homozygous losses
cause early embryonic lethality. Thus, one might expect to ﬁnd
that autophagy-associated proteins, which have indirect links
with ATG proteins, may be more likely to be associated with risk
in diseases where autophagy plays a regulatory role. Nevertheless,
extensive data in model systems and in human brains suggest
modifying roles for autophagy in AD pathogenesis5.
CALM knockdown affects autophagosome formation at two
early steps of the pathway. First, it affects ATG5/ATG12/
ATG16L1 vesicle formation by regulating endocytosis. Although
compromised endocytosis may have multiple effects on neuronal
health, it has clear consequences for autophagy. Speciﬁcally,
it inﬂuences the uptake of plasma membrane lipid into
autophagosome precursor structures12, which we reported by
knocking down key components of the endocytic apparatus, such
as the clathrin heavy chain or a component of the clathrin
adaptor AP2. A second distinct effect of CALM is to inﬂuence the
maturation and enlargement of phagophore precursors and
thereby autophagosome biogenesis by regulating VAMP2 and
VAMP3 endocytosis. These SNAREs associate with pre-
phagophore vesicles in a CALM-dependent manner and are
required for optimal homotypic fusion of ATG16L1 (VAMP2)
vesicles and heterotypic ATG16L1-ATG9A fusion (VAMP3)
in vivo and in vitro16. Thus, CALM regulates both the initial
generation of ATG16L1-associated autophagosome precursors, as
well as their fusion events, which are required for efﬁcient
progression of these structures to the phagophore stage where
they can acquire ATG8 family members16. Our data (Fig. 4a,b)
suggest that CALM-dependent VAMP endocytosis is an
important contributor to its autophagy effects. However, the
relative importance of the different SNAREs is difﬁcult to assess,
and it is possible that CALM additionally has an impact on
autophagy by regulating other intracellular trafﬁcking events.
CALM knockdown also affects autophagosome degradation and
it is likely that this is mediated via its effects on VAMP8, as this
SNARE is known to regulate autophagosome–lysosome fusion.
The dual effects of CALM deﬁciency on autophagy result in a
larger number of autophagosomes in BCs but a failure to
upregulate autophagosome biogenesis in response to starvation.
This situation may be very similar to that occurring in AD
brains4,5.
CALM overexpression also affects autophagy, but this appears
to be independent of VAMP2, VAMP3 or VAMP8 endocytosis,
and is restricted to compromise formation of autophagosomes.
We conﬁrmed this scenario in zebraﬁsh, where CALM over-
expression leads to an accumulation of tau and enhanced toxicity.
This is associated with slower tau clearance in vivo. Indeed, the
Dendra-tau zebraﬁsh allowed us to measure tau clearance in vivo
in a pulse-chase manner, and thus avoid the caveats of measuring
steady-state tau levels in such models, which may be altered by
other processes, such as cell death. The autophagy-inhibitory
effects of CALM overexpression are likely to enhance tau toxicity
by increasing the load of this toxic protein. However, it is possible
that compromised autophagy may additionally increase the
severity of disease in the CALM-overexpressing zebraﬁsh via
additional mechanisms that are independent of the tau levels
(for example, impaired susceptibility to apoptotic insults). Such
Figure 8 | Autophagy and CALM contribute to tau degradation in vivo. (ai) Western blot analysis of tubulin, LC3-I and LC3-II in zebraﬁsh larvae where
ATG7 was downregulated, as indicated. (ii) Western blot analysis of CALM-HA, actin and LC3-II in zebraﬁsh larvae where CALM-HA was expressed, as
indicated. The larvae were treated with ammonium chloride (NH4Cl), as indicated. (SE, short exposure; LE, longer exposure). Quantiﬁcation of LC3-II/actin
ratio is shown. Data are representative of three independent experiments and shown as mean ±s.d. (*Po0.05; two-tailed t-test). (b) Modulation of
autophagy alters Dendra-tau clearance dynamics. The ﬂuorescence intensity of each individual cell was quantiﬁed at each timepoint (nZ 31 cells, Z9
larvae per treatment group) and mean cell intensity values for each drug treatment at each timepoint were calculated. Images were taken immediately after
photoconversion and at 24, 30 and 48 h intervals thereafter. Rapamycin treatment signiﬁcantly increased the rate of Dendra-tau clearance. Ammonium
chloride (NH4Cl) treatment signiﬁcantly decreases the rate of Dendra-tau clearance (**Po0.01, ***Po0.001, one-way analysis of variance (ANOVA)).
Error bars are±s.e.m. (c) Dendra-tau clearance in the presence of CALM: representative images of larvae with mosaic expression of Dendra-tau and full-
length CALM taken immediately after photoconversion and at 6, 24, 30, 48 and 54h after conversion. The ﬂuorescence intensity of individual cells was
quantiﬁed and mean ﬂuorescent intensity of cells co-expressing Dendra-tau and either full-length CALM or D–ANTH CALM (CALM-ANTH-HA)
constructs (nZ 100 cells,Z9 larvae per treatment group) at each time point was calculated. (i) Expression of full-length CALM signiﬁcantly delayed the
clearance of Dendra-tau at all time points compared with D–ANTH CALM (***Po0.001, one-way ANOVA). One graph, representative of three
independent experiments, is presented. (CALM-ANTH-HA: 132 cells, 20 ﬁshes; CALM-HA: 18 cells, 8 ﬁshes). Another two experiments are shown in
Supplementary Fig. S5C. Error bars are mean ±s.d. (ii) Treatment with ammonium chloride alters the dynamics of Dendra-tau clearance. Expression of
full-length CALM signiﬁcantly delayed the clearance of Dendra-tau at all time points compared with D–ANTH CALM, as observed in i (Po0.001,
one-way ANOVA). However, treatment of D–ANTH CALM injected larvae with ammonium chloride slows the Dendra-tau clearance by 70% to a level
comparable to that observed in larvae injected with full-length CALM. Ammonium chloride treatment of larvae injected with full-length CALM results in a
modest (22%) decrease in Dendra-tau clearance, suggesting that CALM overexpression and ammonium chloride treatment have a cumulative effect
(nZ25 cells, nZ9 larvae per treatment group). Error bars are mean ±s.d. Note that i and ii are distinct experiments.
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Figure 9 | Autophagy and CALM modulate photoreceptor degeneration in zebraﬁsh. (a) rho::GFP-tau ﬁshes were incubated from 3 to 9 d.p.f. in either
dimethyl sulphoxide (DMSO) or rapamycin (i) or from 3 to 7 d.p.f in EM alone or 10mM ammonium chloride or 100nM Wortmannin (ii). Images through
the central retina at 9 d.p.f. (top panel; (i)) reveal rod degeneration (arrow) throughout the retina in control (DMSO-treated) larvae, whereas rod
photoreceptors are present throughout the retina, particularly in the central region following treatment with rapamycin (arrow). Images taken through
the central retina at 7 d.p.f. (bottom panel; (ii)) show normal photoreceptors in the marginal zones (arrows) and only limited numbers in the central
region. NH4Cl exacerbates degeneration—photoreceptors are absent from the central retina and reduced/absent from marginal zones (arrows).
Sections were stained with anti-rhodopsin (1D1) antibody. GFP labels whole rod photoreceptors, whereas rhodopsin is present in the rod outer segment.
GFP co-localizes with the red rhodopsin label in all experimental conditions. Scale bars, 50mm. Quantiﬁcation of rod photoreceptor degeneration
(n¼ 10 larvae per group; ***Po0.001; ###Po0.001, two-tailed unpaired t-test). Error bars are mean ±s.d. (b) Full-length CALM electroporation into
rho::GFP larvae did not cause degeneration., while full-length CALM electroporation into rho::GFP-tau larvae exacerbated photoreceptor degeneration.
Central retina sections in the region of the optic nerve head are presented. Scale bars, 50mm. Data represent the ratio (in %) of the intensity of the
GFP signal between CALM-HA electroporated eye versus control eye for ﬁve individuals per transgenic line. ***Po0.05; two-tailed t-test. Error bars are
mean ±s.d. (c) NH4Cl treatment of rho::GFP-tau immediately after unilateral CALM electroporation caused photoreceptor degenerationon the control
(non-electroporated) side but did not alter the degeneration caused by CALM electroporation. Rapamycin treatment of rho::GFP-tau immediately after
unilateral CALM electroporation rescued photoreceptors on the control (non-electroporated) side but not on the CALM-electroporated side. To
demonstrate that loss of GFP corresponds to loss of photoreceptors, sections were stained with anti-rhodopsin (1D1) antibody. Wilcoxon signed rank
test was used to compare the left eye versus the right eye of the same ﬁsh; Mann–Whitney test was used to compare drug treatment in the right
eye of different ﬁshes. *Po0.05. Scale bars, 50mm. Error bars are mean ±s.e.m.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms5998
14 NATURE COMMUNICATIONS | 5:4998 |DOI: 10.1038/ncomms5998 | www.nature.com/naturecommunications
& 2014 Macmillan Publishers Limited. All rights reserved.
possibilities are, however, very difﬁcult to parse out in the in vivo
setting.
In summary, we provide a mechanistic link between a validated
AD risk factor and tau accumulation, which correlates well with
AD pathological and functional deﬁcits. The effect of CALM
locus in AD risk allele(s) on CALM activity has still not been
elucidated. However, a recent study has shown that CALM is
cleaved in AD brains and the level of uncleaved CALM is also
diminished in these patients25. Our cell-based and in vivo data
suggest that both reduced and excessive CALM levels can have an
impact on autophagy and tau levels/clearance, thereby
modulating tau toxicity. Although an autophagy defect is
probably not the only consequence of CALM dysregulation that
contributes to neurodegeneration in AD, this mechanism
provides a link between the genetic risk factor and tau
accumulation, a major pathological hallmark of disease.
Methods
Cell culture. HeLa cells (from American Type Culture Collection (ATCC)) were
cultured in DMEM medium D6546 (Molecular Probes) containing 10% fetal
bovine serum, supplemented with 2mM L-glutamine and 100Uml 1 penicillin/
streptomycin in 5% CO2 at 37 C. HeLa cells stably expressing VAMP2-HA (wild-
type clone 6 and clone 11; mutant clone 11 and clone 12 carrying mutations: Val43
and Met46 mutated to alanines), VAMP3-HA and VAMP8-HA were cultured in
DMEM D6546 containing 10% fetal bovine serum supplemented with 2mM
L-glutamine, 100Uml 1 penicillin/streptomycin and 500mgml 1 G418 (Sigma)
in 5% CO2 at 37 C as previously described27. HeLa cells expressing CALM
constructs (wild-type and mutant) via a retrovirus (Phoenix System) were cultured
in DMEM D6546 containing 10% fetal bovine serum supplemented with 2mM
L-glutamine, 100Uml 1 penicillin/streptomycin, 0.17mgml 1 hygromycin B
and 500 mgml 1 G418 (Sigma) in 5% CO2 at 37 C as previously described32.
HeLa cells stably expressing GFP-LC3 were cultured in DMEM D6546 containing
10% fetal bovine serum supplemented with 2mM L-glutamine, 100Uml 1
penicillin/streptomycin and 500 mgml 1 G418 (Sigma) in 5% CO2 at 37 C.
HEK293 cells (from ATCC) were grown in DMEM containing 10% fetal bovine
serum, supplemented with 100Uml 1 penicillin/streptomycin and puromycin
(5 mgml 1) in 5% CO2 at 37 C. CAD (Cath.-a-differentiated; a central nervous
system catecholaminergic cell line established from a brain tumour in a transgenic
mouse expressing neuron-speciﬁc proteins and synaptic vesicle proteins43) cells
generously provided by Dr D. Chikaraishi, Department of Neurobiology, Duke
University Medical Center, Durham, North Carolina, USA, and grown in DMEM-
F12 media, supplemented with 100Uml 1 penicillin/streptomycin in 5% CO2 at
37 C. Murine embryonic ﬁbroblasts were grown in DMEM supplemented with
non-essential amino acids (Invitrogen) and 100Uml 1 penicillin/streptomycin in
5% CO2 at 37 C as described in ref. 44.
Antibodies and reagents. Antibodies include: rabbit anti-actin (Sigma; ½,000),
rabbit anti-ATG12 (Cell Signalling; 2010; 1/100), goat anti-CALM (Santa Cruz
Biotechnology; sc-6433; 1/500), rabbit anti PICALM (Sigma; 1/1,000), rabbit anti-
LC3 for western blotting (Novus Biologicals; NB100-2220; 14,000), rabbit anti LC3
(Cell Signaling; 2775; 1/1,000), mouse monoclonal anti-LC3 for immuno-
ﬂuorescence (Nanotools; clone 5F10; 1/200), mouse anti-GFP (Clontech; 632569;
1/1,000), mouse anti-p62 (BD Transduction Lab; 610833; 1/1,000), rabbit anti-p62
(Novus Biologicals; NBP1-49954; 1/1,000), goat polyclonal DyLight 680 anti-rabbit
IgG (Licor; 1/4,000) mouse anti-HA (Covance; clone 16B12; 1/1,000), mouse anti-
VAMP2 (SySy, clone 11C3; 1/500), rabbit anti-VAMP8 (SySy; 104302; 1/1,000),
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Figure 10 | CALM modulates the formation of tau-positive tangles in zebraﬁsh. (a) Histological section to demonstrate the individual cell layers of the
zebraﬁsh retina. The photoreceptor layer (PR, comprising rod and cone photoreceptors) lies immediately adjacent to the retinal pigment epithelium (RPE)
at the outermost surface of the eye. Thioﬂavin-S labelling of retinal sections was used to identify neuroﬁbrillary tangles in the photoreceptor layer (marked
with yellow dotted lines). No labelling was observed in the retina of rho::GFP at 8 d.p.f., whereas distinct thioﬂavin-S-positive tangles (arrows) were
observed in the photoreceptor layer of rho::GFP-tau ﬁsh. Note, the RPE is highly autoﬂuorescent due to the presence of silver pigment. High power regions
are shown in the top right of each panel. (b) Unilateral electroporation of CALM into the retina of rho::GFP-tau zebraﬁsh resulted in a marked increase in
thioﬂavin-S positive tangles in the electroporated retina in the photoreceptor layer (PR) compared with the control side. Top panel are lower magniﬁcation
images to show the retinal cell layers. Thioﬂavin-S labelling is restricted to the PR layer. Note the RPE is highly autoﬂuorescent due to the presence of silver
pigment. Bottom panel are higher magniﬁcation images to show individual thioﬂavin-S tangles the largest of which are indicated by arrows.
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mouse anti-GAPDH (Abcam; ab8245; ½,000), rabbit anti-ATG9A (Abcam; 2975-1;
1/200) and mouse anti-phosphorylated tau (PHF1, Thermo; MN1020; 1/200).
Reagents include: Baf A1 (Sigma), cholera toxin subunit B conjugated to
Alexa555 (Invitrogen), transferrin conjugated to Alexa647 (Invitrogen) and EGF
conjugated to Alexa555 (Invitrogen).
Plasmids. pGFP-ATG16L1, pmStrawberry-ATG16L1, pCALM-HA, mCherry-
LC3, LAMP1-GFP and DsRed-tau 4R have been described elsewhere26,45–48.
Cell transfection. The cells were seeded at 1–2 105 per well in six-well plates and
transfection was performed using Lipofectamine or TransIT-2020 (for DNA) or
Lipofectamine 2000 (for siRNA and double transfections with DNA and siRNA)
(Invitrogen, Mirus), using the manufacturer’s protocol. Pre-designed siRNA were
ordered from Thermo Scientiﬁc (Dharmacon Technologies) (siRNA IDs: human
CALM—ON-TARGETplus SMARTpool, human CALM—oligo 5—50-ACAGTTG
GCAGACAGTTTA-30 ; L-004004-00-0005; VAMP2—ON-TARGETplus SMART-
pool and ON-TARGETplus Set of 4, L-012498-00-0005 and LU-012498-00-0002,
respectively; VAMP3—ON-TARGETplus SMARTpool, L-011934-00-0005; and
VAMP8—ON-TARGETplus SMARTpool, L-013503-00-0005). In all experiments
in this paper, we used a scramble siRNA as the control from Thermo Scientiﬁc
(Dharmacon Technologies; D-001810-10-05).
HEK293 and HeLa cells were stably transfected with shRNAs encoding
pRSMX_PG vectors. CAD cells were infected with shRNAs encoding pRSMX_PG
retroviral vectors. Selection of stably transfected/infected cells was performed with
puromycin (Sigma). Details regarding the shRNAs used have been described
previously44. CALM rescue of murine embryonic ﬁbroblasts was performed
using human CALM complementary DNA subcloned into the bicistronic
MSCV-IRES-eGFP retroviral vector44.
Modulation of autophagy in vitro. To inhibit LC3-II degradation, cells were
treated with Baf A1 diluted in cell culture media to a working concentration of
400 nM for 4–6 h, which is saturating for this effect. To induce autophagy in a
mammalian target of rapamycin-dependent manner, cells were amino acid- and
serum-starved or only serum-starved in Hanks balanced salt solution (Sigma) for
1 to 4 h.
Western blotting in vitro. Cells were collected, rinsed with PBS and lysed on ice
for 30min in PBS containing 1% Triton X-100 and complete protease inhibitor
cocktail (Roche). Lysates were centrifuged at 15,000 r.p.m. for 5min at 4 C and
supernatants were resolved by SDS–PAGE and transferred to polyvinylidene
diﬂuoride membranes. The membranes were blocked with TBST (TBS 0.1%
Tween-20) containing 1% non-fat dry milk and were then incubated overnight at
room temperature with primary antibody-diluted TBST. Membranes were washed
with TBST, incubated for 1 h at room temperature with 2,500 dilutions of
horseradish peroxidase-conjugated secondary antibodies (GE Healthcare
Bioscience) in TBST containing 1% non-fat dry milk and washed. Immunoreactive
bands were then detected using ECL (GE Healthcare Bioscience) or by Odyssey
infrared ﬂuorescence imaging (LI-COR Biosciences). Cells were collected, spun
down at 4,200 r.p.m. at 4 C for 10min. Cells were lysed in 2 Laemmli buffer at a
1:1 dilution with PBS. Lysates were resolved by SDS–PAGE electrophoresis (12.5%
gels) and transferred to polyvinylidene diﬂuoride membranes. Membranes were
incubated with the appropriate antibody overnight in Odyssey Blocking Buffer
(LI-COR) with 0.1% Tween-20. Excess antibody was removed by performing three
10-min washes with TBST (0.1% Tween-20). Secondary antibody incubation was
performed in Odyssey Blocking Buffer with 0.1% Tween-20 and 0.02% SDS for
30min. The membranes were washed three times for 5min each. Quantiﬁcation
of proteins normalized to actin or GAPDH (glyceraldehydes 3-phosphate
dehydrogenase) was performed using an Odyssey Infrared Imaging System.
Full blotting images are shown in Supplementary Fig. 9.
Fluorescence and immunoﬂuorescence microscopy in vitro. For immuno-
ﬂuorescence microscopy, cells were cultured on coverslips, ﬁxed with 4%
paraformaldehyde (PFA) in PBS for 5min (for anti-p62, -CALM, -ATG12, -HA
and -VAMP2 antibody) or with ice-cold methanol for 5min (for anti-ATG12,
-CALM and -LC3 antibodies), and permeabilized with 0.1% Triton X-100 in PBS
for 5min. Coverslips were incubated with primary antibodies for 2 h (room
temperature) to 24 h (4 C), washed three times with PBS and incubated with
secondary antibodies for 30min. Samples were mounted using ProLong Gold
antifade reagent with or without DAPI (40,6-diamidino-2-phenylindole; Invitro-
gen) and observed using a Zeiss LSM710 laser confocal microscope. Automatic
counting of ATG12, LC3, Transferrin, EGF and p62 vesicles was performed using
the Thermo Scientiﬁc Cellomics ArrayScan VTI HCS Reader and the Spot Detector
Bioapplication protocole version 3.
Live-cell imaging. For live-cell imaging, HeLa cells were seeded on 42-mm glass
cover slips (PeCon, GmbH, Germany) at a density of B1.5 105 cells per cover
slip. Cells were mounted in a POC chamber (PeCon GmbH) after which they were
imaged immediately at 37 C. Imaging was performed on a Zeiss Axiovert 200M
microscope with a LSM 710 confocal attachment using a  63 1.4 numerical
aperture Plan Apochromat oil-immersion lens. Laser lines at 488 nm
(GFP-ATG16L1) were used. Laser power was kept at a minimum to minimize
photobleaching and photocytotoxicity.
In vitro fusion assay of ATG16L1 vesicles. The assay was performed using the
protocol described previously16. Brieﬂy, two post-nuclear supernatant from HeLa
cells expressing either GFP-ATG16L1 or mStrawberry-ATG16L1 were mixed for
10–60min in the presence of ATP and an ATP regenerative system, immobilized
on glass coverslips and imaged by confocal microscopy, allowing visualization of
double-labelled vesicles.
Vesicle size assays. For measuring the size of ATG12 vesicles, two methods were
used. The ﬁrst method is based on the use of the Thermo Scientiﬁc Cellomics
ArrayScan VTI HCS (High Content Analysis System) Reader and the Spot
Detector Bioapplication protocol version 3, which allowed us to measure the size of
more than 10,000 vesicles per sample. The resolution of the HCS is around 400 nm.
The second method is based on the use of a confocal microscope and image
processing using ImageJ. The size of the vesicles were analysed using the Analyze
Particles protocol. The resolution of this method is around of 150 nm. The data
were statistically analysed using Mann–Whitney test.
Time-course endocytosis assay. Cells were collected and resuspended in ice-cold
serum-free CO2-independent medium and centrifuged for 1min at 7,000 g and
4 C, after which they were resuspended in 300ml of SFM containing
Alexa-647 transferrin (Molecular Probes) and incubated on ice for 5min for
prebinding. They were then incubated for different time (2, 5, 10 and 15min) at
37 C to allow internalization. The cells were chilled on ice, centrifuged and washed
twice with 700 ml PBS, ﬁxed with PFA (4% in PBS) and analysed by ﬂow cytometry.
Immuno-gold electron microscopy. HeLa cells stably expressing GFP-ATG16L1
for 20 h were then ﬁxed with a mixture of 2% PFA and 0.2% glutaraldehyde in PBS
for 2 h, at room temperature. Cells were then prepared for ultrathin cryosectioning
and immunogold labelled, as previously described49. Brieﬂy, ﬁxed cells were
washed once in PBS/0.02M glycine, after which cells were scraped in 12% gelatin in
PBS and embedded in the same solution. The cell-gelatin was cut into 1-mm
blocks, inﬁltrated with 2.3M sucrose at 4 C, mounted on aluminum pins and
frozen in liquid nitrogen. Ultra-thin cryosections were picked up in a mixture of
50% sucrose and 50% methyl cellulose, and incubated with anti-CALM and anti-
GFP, and revealed with 15 nm and 10 nm protein A gold (Utrecht).
Cell spreading assay. Cell spreading assay was performed as previously described
using an automated ﬂuorescence microscope50.
Integrin-trafﬁcking assay. The level of integrin b1 at the cell surface was
measured by ﬂow cytometry after immunostaining with a speciﬁc antibody against
integrin b1 conjugated to ﬂuorescein isothiocyanate (Abcam; ab21845) of cells
ﬁxed with PFA 4% for 2min.
Statistical analysis. Signiﬁcance levels for comparisons between groups were
determined with t-tests, repeated-measure, factorial analysis of variance or
Mann–Whitney using the STATVIEW software, version 4.53 (Abacus Concepts,
Berkeley, CA). For analyses of data where the controls’ absolute values vary in
independent experiments (for example, LC3-II/actin), we have normalized control
values in each experiment to 1 and used a paired t-test—this is the same as a one
sample t-test.
Maintenance of zebraﬁsh stocks and collection of embryos. All zebraﬁsh
experiments were performed in accordance with Home Ofﬁce Guidelines and local
ethical committee approval. Zebraﬁsh were reared under standard conditions on a
14 h light:10 h dark cycle. Embryos were collected from natural spawnings, staged
according to established criteria51 and reared in embryo medium (EM) (5mM
NaCl, 0.17mM KCl, 0.33 mM CaCl2, 0.33mM Mg2SO4, 5mM HEPES) at 28.5 C
in the dark. Wild-type zebraﬁsh were in-crossed descendants of the TL strain. The
rhodopsin::EGFP line (Tg(rho.2:EGFP)cu3)52 was maintained as homozygous line.
Microinjection of CALM in larval zebraﬁsh. Full-length CALM cDNA was
injected into fertilized zebraﬁsh embryos at the one-cell stage. At 14 and 24 h.p.f.,
embryos (n¼ 30 per condition) were transferred to chilled tubes, homogenized in
lysis buffer then processed for western blotting as described above. In a separate set
of experiments, embryos were either exposed to 100mM ammonium chloride or
kept in EM for 4 h before collection for western blotting.
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Generation of rhodopsin::EGFP-MAPT transgenic zebraﬁsh. The fusion
construct of EGFP-MAPT (0N4R)53 (kind gift from Dr Brian Anderton) was
subcloned downstream of the zebraﬁsh rhodopsin promoter54 into a modiﬁed
pEX100T vector (ATCC). Circular DNA was co-injected with IsceI meganuclease
into one-cell stage embryos and larvae with mosaic expression of EGFP in the
retina were reared to adulthood. F0 mosaic ﬁsh were outcrossed to TL ﬁsh to
identify germ line transmitting founders. F1 offspring were reared from 1 d.p.f.
onwards in PTU and screened for EGFP expression in the rod photoreceptors at
4 d.p.f. F1 larvae with EGFP expression were reared to adulthood then incrossed
to generate a homozygous transgenic line. The transgenic line is assigned
Tg(rho:EGFP-tau)cu7 on the ZFIN database and referred to as rho::GFP-tau
hereafter.
Analysis of rod photoreceptor degeneration. Larvae were collected daily from 3
to 9 d.p.f., anaesthetized by immersion in 0.2mgml 1 3-amino benzoic acid
ethylester (MS222) then lysed for western blotting or ﬁxed using 4% PFA in PBS at
4 C for histological and immunohistochemical analysis. For western blotting to
measure endogenous rhodopsin levels, n¼ 30 larvae were collected per time point
and membranes were probed with a mouse monoclonal anti-rhodopsin antibody
(Zpr3, ZIRC) and with Arrestin, Zpr1 (cone-speciﬁc marker) as a loading control.
For histology and immunohistochemical analysis, larvae were washed brieﬂy in
PBS, allowed to equilibrate in 30% sucrose in PBS then embedded in OCT medium
(Tissue-Tek) and frozen on dry ice for subsequent cryosectioning. Sections were
cut at 10-mm thickness using a cryostat (Bright Instruments) and mounted in 80%
glycerol in PBS or Vectashield Hardset mounting medium (Vector Laboratories).
Sections of the central retina, either side of the optic nerve head were imaged using
a Zeiss Axioplan2 microscope, QImaging Retiga 2000 R digital camera and Q
Imaging software. Images of retinal sections were divided into arcs of the central
and margin regions (B110 and 40), respectively, and the number of photo-
receptors in each area was counted by viewing with the naked eye. Mean values for
number of photoreceptors in each region of the retina was calculated for each time
point. IHC analysis using 1D1 (anti-zebraﬁsh rhodopsin, a kind gift from Paul
Linser, University of Florida, FL), AT8 (Pierce Biotechnology), AT270 (Pierce
Biotechnology) or PHF1 (a kind gift from Dr Peter Davies, Albert Einstein College
of Medicine of Yeshiva University, NY) primary antibodies and Alexa 568 or 594
(Invitrogen) secondary antibody was performed on cryosections (n¼ 5 ﬁsh per
antibody). TUNEL (terminal deoxynucleotidyl transferase dUTP nick end) label-
ling was performed using an In Situ Cell Death Detection kit, TMR red (Roche).
Compound treatments in rho::GFP-tau zebraﬁsh. Rho::GFP-tau larvae were
reared from 3 to 9 d.p.f. in EM containing either 0.1% dimethyl sulphoxide or
30mM rapamycin or from 3 to 7 d.p.f in EM alone, 10mM ammonium chloride or
100 nM wortmannin. Compounds and EM were refreshed daily. At the end of the
treatment period, larvae were anaesthetized and ﬁxed with 4% PFA in PBS for the
analysis of rod photoreceptor number.
Electroporation in zebraﬁsh. Electroporation was performed as previously
described55 with the following modiﬁcations: to achieve delivery of DNA to the
photoreceptor layer, the negative electrode was placed into the brain and positive
electrode touching the surface of the lens. A 4:1 ratio of full-length CALM
DNA:dsRed DNA was injected into the orbit (Fig. 3c) and electroporated into the
photoreceptor layer of the right eye of anaesthetized 4 d.p.f. larvae. Larvae were
dark-adapted before electroporation to ensure photoreceptors had intercalated into
the pigment epithelium. Larvae were reared in EM for 24 h then viewed using an
Olympus SZX12 stereoﬂuorescent microscope to identify those with incorporation
of dsRed in the photoreceptors of the right eye. Compound treatments (30 mM
rapamycin or 10mM ammonium chloride) were performed from 4 to 6 d.p.f.
(as described above) with treatment commencing immediately after
electroporation. At 6 d.p.f., larvae were anaesthetized, ﬁxed and processed for
cryosectioning as described above. To assess cell death and tau accumulation,
electroporation was performed without dsRed DNA such that red ﬂuorophores
could be used in subsequent analysis. Sections of the central retina, either side of
the optic nerve head were imaged using a Zeiss Axioplan2 microscope, QImaging
Retiga 2000 R digital camera and Q Imaging software.
Thioﬂavin-S staining in zebraﬁsh. To inhibit death of the photoreceptors, larvae
were treated from 4 d.p.f. onwards with the caspase inhibitor Z-VAD-FMK at
300mM, a concentration previously shown to be effective at inhibiting cell death
without causing toxicity or any adverse physiological effects56. Thioﬂavin-S
staining was performed on cryosections using a modiﬁed Thioﬂavin-S staining
protocol (described previously57).
Generation and microinjection of Dendra-tau constructs. Wild-type human
MAPT (2N4R) in pCDNA3.1 (a gift from Dr Li Gan) was subcloned into
pDendra2 at KpnI and ApaI sites. Dendra-tau was injected into zebraﬁsh embryos
at the one cell stage either alone or in 1:3 ratio with full-length CALM or D–ANTH
CALM constructs. At 24 h.p.f., embryos were viewed using EGFP ﬁlter sets on an
Olympus SZX12 stereoﬂuorescent microscope to identify those with mosaic
expression of Dendra-tau. Dendra ﬂuorescent protein was photoconverted from
green to red by exposure of whole larvae to 365 nm light at 48 h.p.f. Digital images
were captured using GX Optical LED ﬂuorescent microscope, GXCAM3.3 digital
camera and GX Capture software before (M0) and after photoconversion (M1),
and at deﬁned time points thereafter to monitor Dendra-tau clearance.
Compound treatment in Dendra-tau-injected zebraﬁsh. Embryos injected with
Dendra-tau were reared in EM containing either 0.1% dimethyl sulphoxide, 30 mM
rapamycin, 50 mM rilmenidine, 3 mM clonidine or 1mM ammonium chloride from
2 to 5–6 d.p.f. with drugs refreshed daily. Dendra ﬂuorescent protein was photo-
converted from green to red by exposure of whole larvae to 365 nm light at 48 h.p.f.
Digital images were captured using before (M0) and after photoconversion (M1),
and at 24 (M2), 48 (M3), 72 (M4) and 96 h (M5) time points thereafter to monitor
Dendra-tau clearance.
Quantiﬁcation of Dendra-tau clearance in zebraﬁsh. Digital images of ﬂuor-
escent cells in larvae with Dendra-tau mosaic expression were analysed using
ImageJ. The number of red ﬂuorescent cells per larva was counted immediately
after photoconversion and at each time point thereafter. A region of interest was
generated around each cell with Dendra-tau expression and ﬂuorescent intensity
was measured using region of interest and integrated density functions. The
ﬂuorescent intensity of each cell was quantiﬁed at each time point and expressed as
a percentage of the initial ﬂuorescent intensity at M1 (immediately after
photoconversion).
Generation of tau-WT transgenic ﬂies. The cDNA of wild-type human MAPT
(2N4R) in pCDNA3.1 (a gift from Dr Li Gan) was subcloned into the pUASTattB58
vector using the Gateway system (Invitrogen). The DNA was injected into embryos
using the PhiC31 integrase system and the vector inserted on the second
chromosome at the ZH-51D landing site58. The MAPT insertion was veriﬁed by
sequencing across its 50 and 30 junctions with the pUASTattB vector, both before
and after injection.
Western blotting in Drosophila. To assess tau-WT expression level, 20 heads of
ﬂies expressing elav-GAL4 and tau-WT, crossed to either lap UAS-RNAi lines
(lapGD12732 or lapKK105767, VDRC Stock Center, http://stockcenter.vdrc.at/control/
main)37, lap1 (ref. 38) or wild-type control lines, were lysed in sample buffer (4%
SDS, 20% glycerol and 0.125M Tris HCl, pH B6.8). Wild-type control lines were
w1118 (VDRC stocks 60000 and 60100 for lapGD12732 and lapKK105767, respectively),
or Canton S (gift of Simon Collier) for lap1. The tau-WT transgenic line (gift of Mel
Feany) of Wittmann et al.40 was used as a positive control. Lysed supernatant was
run on SDS–PAGE using standard techniques. Proteins were detected using rabbit
anti-tau (1:1,000, ab74391, Abcam), rabbit anti-actin (1:5,000, A2066, Sigma),
rabbit anti-Atg8a (1:5,000, a kind gift from Dr G. Juha´sz)59. IRDye 800CW anti-
rabbit and IRDye 680LT anti-rabbit were used as secondary antibodies and the
signal detected via LI-COR Odyssey Fc dual-mode imaging system. To assess lap
expression levels, SDS–PAGE western blottings were probed with a guinea pig
anti-lap polyclonal antiserum (a kind gift from Dr B. Zhang, similar to the rat anti-
serum used previously38) used at a dilution of 1:3,000 with a secondary horseradish
peroxidase-labelled anti-guinea pig IgG. Full blotting images are shown in
Supplementary Fig. 9.
Characterisation of Drosophila tau-WT transgenic lines. Virgins of the drivers
tubulin-GAL4 (P{tubP-GAL4}LL7 (ref. 60)), GMR-GAL4 (P{GAL4-ninaE.GMR}
12 (ref. 61)), eyeless-GAL4 (ey-GAL4, P{GAL4-ey.H}3-8 (ref. 62)), elav-GAL4
(elav-GAL4C155 (ref. 63)), D42-GAL4 (P{GawB}D42 (ref. 64)), CCAP-GAL4
(P{CCAP-GAL4.P}16 and P{CCAP-GAL4.P}9 (ref. 65)), NSyb-GAL4 1-2 (gift
of Dr Julie Simpson) were crossed with males carrying UAS-tau-WT.
Drosophila lap KK-RNAi line lapKK105767. We veriﬁed that the lapKK105767UAS-
RNAi line was not inserted at the landing site that affected the tio gene66 by
crossing virgins of elav-GAL4C155 (ref. 63) with either lapKK105767 or w1118 (60100
stock, VDRC Stock Center, http://stockcenter.vdrc.at/control/main) males. The
progeny of both crosses had normally inﬂated wings, suggesting that they harbour
the targeted insertion at the anticipated genomic site66.
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